Logo image of IFX.CA

IMAFLEX INC (IFX.CA) Stock Fundamental Analysis

TSX-V:IFX - CA4524352099 - Common Stock

1.2 CAD
0 (0%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

6

Overall IFX gets a fundamental rating of 6 out of 10. We evaluated IFX against 8 industry peers in the Containers & Packaging industry. While IFX has a great health rating, its profitability is only average at the moment. IFX may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, IFX could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IFX had positive earnings in the past year.
IFX had a positive operating cash flow in the past year.
IFX had positive earnings in each of the past 5 years.
IFX had a positive operating cash flow in each of the past 5 years.
IFX.CA Yearly Net Income VS EBIT VS OCF VS FCFIFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

IFX has a Return On Assets of 6.38%. This is in the better half of the industry: IFX outperforms 75.00% of its industry peers.
IFX has a worse Return On Equity (9.05%) than 62.50% of its industry peers.
IFX's Return On Invested Capital of 8.12% is fine compared to the rest of the industry. IFX outperforms 62.50% of its industry peers.
IFX had an Average Return On Invested Capital over the past 3 years of 7.65%. This is in line with the industry average of 8.04%.
The last Return On Invested Capital (8.12%) for IFX is above the 3 year average (7.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.38%
ROE 9.05%
ROIC 8.12%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
IFX.CA Yearly ROA, ROE, ROICIFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 5.28%, IFX is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
IFX's Profit Margin has improved in the last couple of years.
IFX has a Operating Margin of 7.36%. This is in the lower half of the industry: IFX underperforms 62.50% of its industry peers.
IFX's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 16.75%, IFX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IFX has grown nicely.
Industry RankSector Rank
OM 7.36%
PM (TTM) 5.28%
GM 16.75%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
IFX.CA Yearly Profit, Operating, Gross MarginsIFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IFX is still creating some value.
IFX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for IFX has been increased compared to 5 years ago.
Compared to 1 year ago, IFX has an improved debt to assets ratio.
IFX.CA Yearly Shares OutstandingIFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IFX.CA Yearly Total Debt VS Total AssetsIFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 3.93 indicates that IFX is not in any danger for bankruptcy at the moment.
IFX's Altman-Z score of 3.93 is amongst the best of the industry. IFX outperforms 87.50% of its industry peers.
IFX has a debt to FCF ratio of 0.64. This is a very positive value and a sign of high solvency as it would only need 0.64 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.64, IFX belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
IFX has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
IFX has a better Debt to Equity ratio (0.11) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.64
Altman-Z 3.93
ROIC/WACC1.05
WACC7.73%
IFX.CA Yearly LT Debt VS Equity VS FCFIFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

IFX has a Current Ratio of 2.44. This indicates that IFX is financially healthy and has no problem in meeting its short term obligations.
IFX has a Current ratio of 2.44. This is in the better half of the industry: IFX outperforms 75.00% of its industry peers.
A Quick Ratio of 1.65 indicates that IFX should not have too much problems paying its short term obligations.
IFX has a Quick ratio of 1.65. This is in the better half of the industry: IFX outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.65
IFX.CA Yearly Current Assets VS Current LiabilitesIFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

IFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 311.68%, which is quite impressive.
The Earnings Per Share has been growing by 36.43% on average over the past years. This is a very strong growth
The Revenue has grown by 13.92% in the past year. This is quite good.
IFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.26% yearly.
EPS 1Y (TTM)311.68%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-85.63%
Revenue 1Y (TTM)13.92%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%5.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y366.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.85%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IFX.CA Yearly Revenue VS EstimatesIFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
IFX.CA Yearly EPS VS EstimatesIFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.91, the valuation of IFX can be described as reasonable.
IFX's Price/Earnings ratio is a bit cheaper when compared to the industry. IFX is cheaper than 75.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of IFX to the average of the S&P500 Index (27.13), we can say IFX is valued rather cheaply.
The Price/Forward Earnings ratio is 8.32, which indicates a very decent valuation of IFX.
IFX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IFX is cheaper than 62.50% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, IFX is valued rather cheaply.
Industry RankSector Rank
PE 10.91
Fwd PE 8.32
IFX.CA Price Earnings VS Forward Price EarningsIFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IFX indicates a rather cheap valuation: IFX is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IFX indicates a rather cheap valuation: IFX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.21
EV/EBITDA 4.7
IFX.CA Per share dataIFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

IFX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IFX may justify a higher PE ratio.
PEG (NY)0.03
PEG (5Y)0.3
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IFX!.
Industry RankSector Rank
Dividend Yield N/A

IMAFLEX INC

TSX-V:IFX (8/29/2025, 7:00:00 PM)

1.2

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)05-27 2025-05-27/bmo
Earnings (Next)09-02 2025-09-02
Inst Owners10.17%
Inst Owner ChangeN/A
Ins Owners46.37%
Ins Owner ChangeN/A
Market Cap62.51M
Analysts84.44
Price Target2.04 (70%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)180%
EPS NY rev (3m)180%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 10.91
Fwd PE 8.32
P/S 0.56
P/FCF 4.21
P/OCF 3.5
P/B 0.96
P/tB 1
EV/EBITDA 4.7
EPS(TTM)0.11
EY9.17%
EPS(NY)0.14
Fwd EY12.02%
FCF(TTM)0.28
FCFY23.74%
OCF(TTM)0.34
OCFY28.58%
SpS2.14
BVpS1.25
TBVpS1.2
PEG (NY)0.03
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 6.38%
ROE 9.05%
ROCE 10.89%
ROIC 8.12%
ROICexc 9.07%
ROICexgc 9.39%
OM 7.36%
PM (TTM) 5.28%
GM 16.75%
FCFM 13.32%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
ROICexc(3y)8.55%
ROICexc(5y)12.05%
ROICexgc(3y)8.89%
ROICexgc(5y)12.53%
ROCE(3y)10.53%
ROCE(5y)14.7%
ROICexcg growth 3Y-20.84%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y5.71%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
F-Score8
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.64
Debt/EBITDA 0.54
Cap/Depr 55.28%
Cap/Sales 2.71%
Interest Coverage 11.69
Cash Conversion 130.75%
Profit Quality 252.52%
Current Ratio 2.44
Quick Ratio 1.65
Altman-Z 3.93
F-Score8
WACC7.73%
ROIC/WACC1.05
Cap/Depr(3y)236.8%
Cap/Depr(5y)164.27%
Cap/Sales(3y)10.14%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)311.68%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-85.63%
EPS Next Y366.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.92%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%5.54%
Revenue Next Year22.85%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y128.96%
EBIT growth 3Y-9.43%
EBIT growth 5Y14.73%
EBIT Next Year119.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y918.3%
FCF growth 3Y29.22%
FCF growth 5Y23.11%
OCF growth 1Y2.46%
OCF growth 3Y25.19%
OCF growth 5Y10.31%